Navigation Links
Cantel Medical's Mar Cor Purification Subsidiary Acquires Hemodialysis Water Business from Siemens' Water Technologies Business Unit
Date:3/25/2013

LITTLE FALLS, N.J., March 25, 2013 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE: CMN), through its Mar Cor Purification subsidiary, has continued the expansion of its water purification and filtration unit with the purchase of the hemodialysis water business from Siemens' Water Technologies business unit. With approximately 600 dialysis customers in the United States and Canada and 2012 revenue of approximately $9 million, this acquisition significantly expands Mar Cor Purification's North American footprint. The acquisition is expected to be slightly accretive to Cantel Medical's earnings per share in fiscal year 2013 and beyond.

Curtis Weitnauer , President and CEO of Mar Cor Purification, stated, "The acquisition of the Siemens hemodialysis water customer base enables Mar Cor to realize increased efficiencies from our existing field service operations while also expanding our footprint into new geographies.  With this geographic expansion, Mar Cor will further improve its ability to service its large national customers.  We look forward to continuing to provide our unique dialysis products and services to our new and existing customers."

Cantel Medical's President and CEO, Andrew Krakauer , added, "This acquisition strengthens our position as a leading provider of water purification products and services to the dialysis industry.  Our advanced heat-based disinfection water technology coupled with our nationwide service footprint makes Mar Cor the best choice for infection prevention and control to our dialysis customers.   We remain confident that our water purification and filtration segment will continue to demonstrate industry leading performance."

About Mar Cor Purification, Inc.

A subsidiary of Cantel Medical Corp., Mar Cor Purification is dedicated to providing innovative solutions through filtration, water purification, and disinfection technologies to the medical, life science and industrial marketplaces. Mar Cor Purification has service offices in 22 cities in the U.S. and Canada, with 7 resin regeneration plants strategically located in Atlanta, Boston, Chicago, Philadelphia, San Antonio, Montreal and Toronto. For more information please visit http://www.mcpur.com.       

About Cantel Medical Corp.

Cantel Medical Corp. (NYSE: CMN) is a leading provider of infection prevention and control products in the healthcare market. Our products include water purification equipment, sterilants, disinfectants and cleaners, specialized medical device reprocessing systems for endoscopy and renal dialysis, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates and other dialysis supplies, hollow fiber membrane filtration and separation products for medical and non-medical applications, and specialty packaging for infectious and biological specimens. We also provide technical maintenance for our products and offer compliance training services for the transport of infectious and biological specimens. 

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties, including, without limitation, the risks detailed in Cantel's filings and reports with the Securities and Exchange Commission. Such forward-looking statements are only predictions, and actual events or results may differ materially from those projected or anticipated.


'/>"/>
SOURCE Cantel Medical Corp.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Cantel Medical Reports EPS of $0.38 vs. $0.27 on 9% Sales Increase for Second Quarter Ended January 31, 2013
2. Cantel Medical Reports EPS of $0.35 vs. $0.23 for First Quarter Ended October 31, 2012
3. Cantel Medical Appoints Jorgen B. Hansen As Executive Vice President And Chief Operating Officer
4. Cantel Medical Corp. To Present At The CL King 10th Annual Best Ideas Conference
5. Cantel Medical Board Of Directors Authorizes Regular Semiannual Dividend
6. IQAirs New Edition Redefines High-Performance Air Purification
7. Takeda Launches New Subsidiary in Ecuador
8. Generex Touts Pipeline Potential of Antigen Express Subsidiary
9. Novation Holdings Announces Sale of Subsidiary
10. Golden Meditech Holdings Limited Announces Updates on Medical Devices Subsidiary Latest Development
11. China Biologics Guizhou Taibang Subsidiary Donates Lifesaving Plasma Products for the Injured in the Yunnan Earthquake
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... Bracket , a leading clinical trial technology and specialty ... Bracket eCOA (SM) 6.0, at the 52 nd ... in Philadelphia , Pennsylvania.  A demonstration of ... its kind to fully integrate with RTSM, will be held ... a flexible platform for electronic clinical outcomes assessments that is ...
Breaking Medicine Technology:
(Date:6/26/2016)... Charlotte, NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind ... able to be personalized through a fitness app. The fitness app plans to fix the ... solutions currently only offer a one size fits all type program , They ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery ... of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , ... for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/25/2016)... ... 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the Maryland ... iHire in recognition of their exemplary accomplishments in worksite health promotion. , The Wellness ... & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one of ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may ... to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To ... for healthy coping following a traumatic event. , Trauma sufferers tend to feel a ...
Breaking Medicine News(10 mins):